Advocacy Update ~ April 9, 2018

This post was written by Danielle Heiberg, Senior Policy & Advocacy Manager, and Melissa Chacko, Policy Associate.

The past two weeks were relatively quiet on Capitol Hill as Congress was in recess. Below are items that we are tracking:

Possible Rescission package

President Trump and Republicans are in discussions to force a vote on a package that would cut billions from the recently passed FY 2018 $1.3 trillion Omnibus. Although, the Omnibus was passed with bipartisan support, Republicans are facing pressure over the large spending package. There is no word on which accounts would be targeted or when a vote would take place.

Pompeo Nomination for Secretary of State

Please see below the nomination hearing date for The Honorable Mike Pompeo of Kansas as Secretary of State. For more information, visit: https://bit.ly/2qgKvaZ

1) Committee: Senate Foreign Relations Committee
2) Date: Thursday, April 12, 2018
3) Time: 10:00 am
4) Location: SD-419

 Moving Forward – FY 2019

As the FY 2019 process moves along, we hope that Congress again rejects the cuts proposed in the President’s budget which contains a 30 percent decrease in the foreign affairs budget, including global health programs at the U.S. Agency for International Development (USAID) and Department of State and cuts that were recommended for programs at the Department of Health and Human Services that support global health, global health research and development, and global health security.

Since the time that the President released his budget, advocates have been on the Hill, lobbying for strong investments in global health and submitting appropriation requests to members of Congress.

See Global Health Council’s funding chart: Funding Chart (FY 2017 comparison to FY 2018, and includes FY 2019)

Global Health Innovation Act Reviewed in the Senate Foreign Relations Committee

The Global Health Innovation Act (H.R. 1660) introduced by Representative Albio Sires (D-NJ) was reviewed by the Senate Foreign Relations Committee and reported favorably without amendment. The bill supports global health research and development by encouraging the development of health products that are affordable, accessible, and culturally appropriate in low-resource health systems. This bill will require USAID to submit a report on the development and use of global health innovations at the agency.